76 related articles for article (PubMed ID: 6032012)
41. Normal & malignant tissues--an investigation by pulsed nuclear magnetic resonance.
Chaughule RS; Kasturi SR; Vijayaraghavan R
Indian J Biochem Biophys; 1974 Sep; 11(3):256-8. PubMed ID: 4469255
[No Abstract] [Full Text] [Related]
42. Host-tumour relationship. XXII. Hydroxyproline excretion in the course of tumour growth and sterile abscess in rats.
Vermousek I; Brada Z; Tobiska J
Neoplasma; 1967; 14(1):59-65. PubMed ID: 6047726
[No Abstract] [Full Text] [Related]
43. Marked induction of HSP47, a collagen-binding stress protein, during solid tumor formation of ascitic Sarcoma 180 in vivo.
Morino M; Tsuzuki T; Iijima H; Shirakami T; Kiyosuke YI; Ishikawa Y; Yoshimura M; Yoshikumi C
In Vivo; 1995; 9(5):503-8. PubMed ID: 8900930
[TBL] [Abstract][Full Text] [Related]
44. [DNA biosynthesis in the liver of animals with extrahepatic tumors: the role of thymidylate synthetase].
Gómez C; Montañés I; Vicente J
Rev Clin Esp; 1980 Nov; 159(3):163-6. PubMed ID: 7465893
[No Abstract] [Full Text] [Related]
45. [Evaluation of cell cycle parameters].
Okumura Y; Onozawa M; Matsuzawa T; Morita H
Nihon Igaku Hoshasen Gakkai Zasshi; 1971 Nov; 31(8):959-63. PubMed ID: 5292068
[No Abstract] [Full Text] [Related]
46. Nucleolar silver stained granules in rat Yoshida sarcoma cells after RNA synthesis inhibition.
Kacerovská H; Likovský Z; Smetana K
Neoplasma; 1981; 28(5):513-6. PubMed ID: 7312072
[TBL] [Abstract][Full Text] [Related]
47. Field bean protease inhibitor preparations, unlike methotrexate, can completely suppress Yoshida sarcoma tumor in rats.
Banerji AP; Fernandes AO
Cell Biol Int; 1994 Nov; 18(11):1025-34. PubMed ID: 7894388
[TBL] [Abstract][Full Text] [Related]
48. Effects of glutamate dehydrogenase, choline oxidase, and glucose-6-phosphatase on 67Ga accumulation in lysosome.
Li SL; Ando A; Ando I
Zhongguo Yao Li Xue Bao; 1995 Jan; 16(1):51-3. PubMed ID: 7771197
[TBL] [Abstract][Full Text] [Related]
49. A further study on the number of silver stained granules of active nucleolus organizer regions in mitotic Yoshida and Zajdela rat experimental tumor cells.
Likovský Z; Pokorná D; Smetana K
Neoplasma; 1982; 29(4):441-5. PubMed ID: 6182476
[TBL] [Abstract][Full Text] [Related]
50. Studies on "Ascites sarcoma".
Kitagawa T
Proc Jpn Acad Ser B Phys Biol Sci; 2024; 100(6):309-319. PubMed ID: 38866478
[TBL] [Abstract][Full Text] [Related]
51. Effects of cytochalasin B and colchicine on the motility and growth of Yoshida sarcoma cells in vitro.
Hosaka S; Suzuki MS; Sato H
Sci Rep Res Inst Tohoku Univ Med; 1980 Dec; 27(1-4):27-31. PubMed ID: 7313677
[TBL] [Abstract][Full Text] [Related]
52. [Oncolytic power in vivo of the Newcastle virus with regard to sarcoma ascitic Yoshida].
Jacotot H
C R Acad Hebd Seances Acad Sci D; 1967 May; 264(22):2602-3. PubMed ID: 4293773
[No Abstract] [Full Text] [Related]
53. Researches on the mother cell of Yoshida's tumor and on its carcinogenic factors.
HAMAZAKI Y; SATO J; NAGANO S
Gan; 1950 Dec; 41(2-4):109-13. PubMed ID: 14802569
[No Abstract] [Full Text] [Related]
54. [Experimental metastasis formation by means of intravenous transplantation of tumor cells: studies by the Yoshida sarcoma and the rat ascites hepatomas].
TAKITA J
Tohoku Igaku Zasshi; 1962 Apr; 65():384-401. PubMed ID: 13984721
[No Abstract] [Full Text] [Related]
55. Comparison of nitrogen mustard sensitive and resistant Yoshida sarcomas. II. Effect of treatment on cell kinetics.
Ball CR; Connors TA; Cooper EH; Topping NE
Neoplasma; 1967; 14(3):253-64. PubMed ID: 6063004
[No Abstract] [Full Text] [Related]
56. Cellular multiplication in Yoshida ascitic tumor in the rat after electrothermocoagulation of the tuberoinfundibular region of the hypothalamus.
Bindoni M; Belluardo N; Licciardello S; Marchese AE; Cicirata F
Exp Neurol; 1980 Feb; 67(2):433-7. PubMed ID: 6985590
[No Abstract] [Full Text] [Related]
57. Effect of immunization against human chorionic gonadotropin (hCG) on transplantation of Yoshida ascitic tumour.
Bernardini A; Corbino N; Rapisarda Proto G; Iacona G; Stivala F
Microbiologica; 1982 Oct; 5(4):383-8. PubMed ID: 7154977
[TBL] [Abstract][Full Text] [Related]
58. [Reoxygenation in Yoshida sarcoma during different fractionated radiotherapy].
Strnad V; Kamprad F; Jahns J; Kirschner M; Meyer M; Madaj-Sterba P; Riepl M; Böhme R; Sauer R
Strahlenther Onkol; 1996 Nov; 172(11):619-25. PubMed ID: 8975393
[TBL] [Abstract][Full Text] [Related]
59. Erythrocytes from Yoshida ascites sarcoma-bearing rats have reduced surface charge: the effect of tumor products.
Pestonjamasp VK; Mehta NG
Cancer Biochem Biophys; 1995 Jun; 15(1):19-23. PubMed ID: 8536216
[TBL] [Abstract][Full Text] [Related]
60. Tempicol-3, a novel piperidine-N-oxide stable radical and antioxidant, with low toxicity acts as apoptosis inducer and cell proliferation modifier of Yoshida Sarcoma cells in vivo.
Koceva-Chyła A; Kochman A; Głebska J; Gwoździnski K; Jóźwiak Z; Metodiewa D
Anticancer Res; 2000; 20(6B):4611-8. PubMed ID: 11205311
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
